IMKASID 2025

PE2-02 Poster Exhibition
View : 13
Smoking, Alcohol Consumption, Physical Activity and Risk of Inflammatory Bowel Disease in Patients with Psoriasis: A Nationwide, Population-based Study in Korea

Presenting Author : Min-Jae Kim (Yonsei University College of Medicine, Korea)
PE2-03 Poster Exhibition
View : 16
Impact of Body Mass Index on Clinical Remission, Drug Persistence, and Trough Levels with Subcutaneous Infliximab in Patients with Crohn's Disease

Presenting Author : Kyuwon Kim (Chung-Ang University Hospital, Korea)
PE2-04 Poster Exhibition
View : 12
Cancer Incidence in Patients with Inflammatory Bowel Disease: A Nationwide Population-based Study

Presenting Author : Jeongkuk Seo (Chung-Ang University College of Medicine, Korea)
PE2-05 Poster Exhibition
View : 4
Reliability and Validity of Texture and Colour Enhancement Imaging (TXI) to Assess Mucosal Inflammation in Ulcerative Colitis

Presenting Author : Deloshaan Subhaharan (Gold Coast University Hospital, Bond University, Australia)
PE2-06 Poster Exhibition
View : 5
Trends and Impacts of Advanced Therapy on Chronic Opioid Use among Patients with Inflammatory Bowel Disease: A Korean Nationwide Population-based Study

Presenting Author : Yu Kyung Jun (Seoul National University Bundang Hospital, Seoul National University College of Medicine, Korea)
PE2-07 Poster Exhibition
View : 5
Tight Monitoring with Colonoscopy and Magnetic Resonance Enterography Promotes Treatment Adjustments and Improves Long-Term Outcomes in Advanced Treatment-naive Patients with Crohn’s Disease

Presenting Author : Soyun Lim (Seoul National University College of Medicine, Korea)
PE2-08 Poster Exhibition
View : 6
Comparison of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease Before Anti-uumor Necrosis Factor-agents Therapy: TST-Alone Versus a Combination of TST and IGRA

Presenting Author : Sang Hyoung Park (Asan Medical Center, University of Ulsan College of Medicine, Korea)
PE2-09 Poster Exhibition
View : 12
A New Attempt to Explore Useful Serological Indices for Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis

Presenting Author : Kei Moriya (Nara Prefecture General Medical Center, Japan)
PE2-10 Poster Exhibition
View : 15
Efficacy of Guselkumab Versus Placebo in Crohn’s Disease Based On on Prior Response/Exposure to Biologic Therapy: Results of the GALAXI 2 & 3 Phase 3 Studies

Presenting Author : Tae Oh Kim (Department of Internal Medicine, Inje University Haeundae Paik Hospital, Korea)
PE2-11 Poster Exhibition
View : 10
Red Flags Index for Detecting Crohn’s Disease in the Korean Population: Development and Validation in High Risk Population of IBD

Presenting Author : Ock Kim (Seoul National University College of Medicine, Korea)
PE2-12 Poster Exhibition
View : 6
One-year Effectiveness and Safety of Ustekinumab Treatment in Patients with Ulcerative Colitis: An Asan-Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD) Multicentre Real-world Cohort Study

Presenting Author : Ji Eun Baek (University of Ulsan College of Medicine, Asan Medical Center, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Korea)
PE2-13 Poster Exhibition
View : 8
Efficacy and safety of oral sulphate tablet for Bowel Preparation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Cohort Study

Presenting Author : Joo Hye Song (Konkuk university medical center, Korea)
PE2-14 Poster Exhibition
View : 8
Comparative Clinical Outcomes of Advanced Therapy in Bio-naive versus Bio-experienced Patients Hospitalized with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study

Presenting Author : Sung Wook Hwang (Asan Medical Center, University of Ulsan College of Medicine, Korea)
PE2-15 Poster Exhibition
View : 5
Efficacy and Drug Survival of Subcutaneous Infliximab after Switching from Intravenous Therapy in Patients with Inflammatory Bowel Disease: A 2-year Multicenter Real-world Study in Korea

Presenting Author : Kyuwon Kim (Chung-Ang University Hospital, Korea)
PE2-16 Poster Exhibition
View : 4
COVID-19 Risk in Patients with Autoimmune Diseases Using Biologics or Small Molecules: A Population-based Cohort Study

Presenting Author : Chang Mo Moon (Gibbeum Hospital, Korea)
PE2-18 Poster Exhibition
View : 7
Effectiveness of an App-based Walking Program for Obese Patients with Inflammatory Bowel Disease in Korea: A Single-blind Parallel-group Randomized Clinical Trial

Presenting Author : Sang Hyoung Park (University of Ulsan College of Medicine, Asan Medical Center, Korea)
PE2-19 Poster Exhibition
View : 4
Artificial Intelligence-based Prediction of Nancy Histologic Index Using Digital Pathology in Ulcerative Colitis Patients

Presenting Author : Ji Eun Kim (Samsung Medical Center, Korea)
PE2-20 Poster Exhibition
View : 4
Week 48 Efficacy of Guselkumab and Ustekinumab in Crohn’s Disease Based on Prior Response/Exposure to Biologic Therapy: Results from the GALAXI 2 & 3 Phase 3 Studies

Presenting Author : Tae Oh Kim (Department of Internal Medicine, Inje University Haeundae Paik Hospital, Korea)
PE2-21 Poster Exhibition
View : 1
Reliability and Validity of Linked Color Imaging (LCI) to Assess Mucosal Inflammation in Ulcerative Colitis

Presenting Author : Deloshaan Subhaharan (Gold Coast University Hospital, Bond University, Australia)
PE2-22 Poster Exhibition
View : 3
The Association of Type of Aminosalicylates and the Timing of Initiation of Immunomodulators in Crohn's Disease

Presenting Author : One-Zoong Kim (Uijeongbu Eulji Medical Center, Eulji University, Korea)